Financials

News Ideas Discussions Technicals Forecast Seasonals

CRSP fundamentals

Overview Statements Statistics Dividends Earnings Revenue

The current financial position of CRISPR Therapeutics AG

Total assets of CRSP for Q3 24 is 2.26 B USD, 3.58% less than the previous Q2 24. And total liabilities decreased by 11.82% in Q3 24 to 316.47 M USD.

Q1 '23

Q2 '23

Q3 '23

Q4 '23

Q1 '24

Q2 '24

Q3 '24

‪0.00‬

Total assets

Total liabilities

Income statement Balance sheet Cash flow

Currency: USD

Q1 '23

Q2 '23

Q3 '23

Q4 '23

Q1 '24

Q2 '24

Q3 '24

YoY growth

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—